CDNA
Overvalued by 152.3% based on the discounted cash flow analysis.
Market cap | $760.94 Million |
---|---|
Enterprise Value | $571.92 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-3.44 |
Beta | 0.0 |
Outstanding Shares | 52,083,792 |
Avg 30 Day Volume | 695,458 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -4.15 |
---|---|
PEG | 13.91 |
Price to Sales | 2.71 |
Price to Book Ratio | 3.39 |
Enterprise Value to Revenue | 2.08 |
Enterprise Value to EBIT | -5.73 |
Enterprise Value to Net Income | -4 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.1 |
No data
No data